| Literature DB >> 32472938 |
Diana P Pires1, Ana Rita Costa2, Graça Pinto1, Luciana Meneses1, Joana Azeredo1.
Abstract
Antibiotic resistance is a major public health challenge worldwide, whose implications for global health might be devastating if novel antibacterial strategies are not quickly developed. As natural predators of bacteria, (bacterio)phages may play an essential role in escaping such a dreadful future. The rising problem of antibiotic resistance has revived the interest in phage therapy and important developments have been achieved over the last years. But where do we stand today and what can we expect from phage therapy in the future? This is the question we set to answer in this review. Here, we scour the outcomes of human phage therapy clinical trials and case reports, and address the major barriers that stand in the way of using phages in clinical settings. We particularly address the potential of phage resistance to hinder phage therapy and discuss future avenues to explore the full capacity of phage therapy.Entities:
Keywords: One-Health; clinical trials; phage cocktails; phage engineering; phage resistance; regulatory framework
Year: 2020 PMID: 32472938 DOI: 10.1093/femsre/fuaa017
Source DB: PubMed Journal: FEMS Microbiol Rev ISSN: 0168-6445 Impact factor: 16.408